Introduction: Sexually transmitted Infections (STIs) pose a significant public health challenge, especially in vulnerable populations such as riverine communities in the Amazon. They face barriers to accessing health services, limited sexual education and unfavorable socioeconomic conditions, factors that contribute to the high prevalence of STIs and their complications, including cancer. HPV (Human Papillomavirus), for example, is associated with cervical cancer, while hepatitis B and C can lead to liver cancer. In this context, it is crucial to understand the relationship between STIs and cancer, prevention strategies and control strategies. Objectives: analyze the prevalence of STIs and their association with cancer in a riverside population. Methods: An observational, cross-sectional study with a quantitative approach was conducted in a riverside community located in the state of Pará. The sample consisted of 46 randomly selected adults. Structured questionnaires were applied to collect sociodemographic, behavioral, and health history data. In addition, rapid tests were performed to detect HIV, syphilis, hepatitis B and C, and material was collected for HPV analysis. Data were analyzed using descriptive and inferential statistics, using SPSS software. CAAE: 84606024.9.0000.5173, Opinion Number: 7.331.126. Results: Indicated a significant prevalence of STIs in the population studied. Syphilis had a rate of 6.15%, HIV 0.61%, and coinfection was observed in 0.61% of cases. HPV analysis revealed a high rate of infection, especially among women over 40 years of age. In addition, factors such as multiple sexual partners, low educational level, lack of condom use, and lack of access to health services were identified as determinants for the higher prevalence of STIs. It was also observed that the lack of diagnosis and adequate treatment contributes to the evolution of infections to more serious stages, including cancer. Conclusion: The high prevalence of STIs and their association with cancer in the riverside population of northern Brazil highlights the urgent need for public policies targeting this community. It is essential to implement health education programs, expand access to diagnostic and treatment services, and promote awareness about the importance of condom use and regular examinations.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
